🇰🇷 Alogliptin and metformin in South Korea

Alogliptin and metformin (Alogliptin and metformin) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Alogliptin and metformin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Alogliptin and metformin approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Alogliptin and metformin in South Korea?

Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.